MEITHEAL Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MEITHEAL, and what generic and branded alternatives to MEITHEAL drugs are available?
MEITHEAL has seventy-eight approved drugs.
Summary for MEITHEAL
US Patents: | 0 |
Tradenames: | 65 |
Ingredients: | 64 |
NDAs: | 78 |
Patent Litigation for MEITHEAL: | See patent lawsuits for MEITHEAL |
Drugs and US Patents for MEITHEAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Meitheal | MITOMYCIN | mitomycin | INJECTABLE;INJECTION | 214505-002 | Sep 8, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Meitheal | THIOTEPA | thiotepa | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | 216037-002 | Dec 26, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Meitheal | DEXMEDETOMIDINE HYDROCHLORIDE | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 204843-001 | Jan 18, 2019 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Meitheal | CYTARABINE | cytarabine | INJECTABLE;INJECTION | 208485-001 | Feb 28, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Meitheal | VORICONAZOLE | voriconazole | INJECTABLE;INTRAVENOUS | 214516-001 | May 9, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for MEITHEAL drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 250 mcg/0.5 mL, 1 mL PFS | ➤ Subscribe | 2012-03-30 |
Similar Applicant Names
Here is a list of applicants with similar names.